Title : Design, synthesis, in vitro antiproliferative evaluation and in silico studies of new VEGFR-2 inhibitors based on 4-piperazinylquinolin-2(1H)-one scaffold.

Pub. Date : 2022 Mar

PMID : 35091289






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sorafenib is an FDA approved cancer therapeutic with activity against many protein kinases, including VEGFR. Sorafenib kinase insert domain receptor Homo sapiens